Answers are grounded in this paper and cite their sources.
Xanthogranulomatous giant cell-rich tumor (XGCT) is a recently described exceptionally rare mesenchymal neoplasm. It is considered an emerging mesenchymal neoplasm with limited characterization in the literature. We report a case of a 56-year-old female presenting with a painless anterior chest wall mass. Cross-sectional imaging revealed an expansile, solid-enhancing lesion centered at the left second rib and costochondral cartilage. PET-CT demonstrated high-grade metabolic activity (SUV max 14.5). Biopsy confirmed a keratin-positive/xanthogranulomatous giant cell-rich tumor, a recently described low-grade soft tissue and bone neoplasm associated with HMGA2/NCOR2 gene fusion. The patient underwent surgical resection; however, the final pathology showed focally positive margins. Given the rarity of the tumor and its presumed indolent behavior, the imaging characteristics on computed tomography, and magnetic resonance imaging as well as the management was reviewed and discussed at a Provincial Multidisciplinary Sarcoma Round, where consensus favored postoperative surveillance. The patient continues to do well clinically, and follow-up imaging is planned to monitor for recurrence.
No takes yet. Share an insight, caveat, or question.
Aludaini et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: